Effect of Fibroid Location and Size on Efficacy of Elagolix: Results from Phase 3 Clinical Trials

Ayman Al‐Hendy, Jean-Marc Simon, Sandra Hurtado, LD Bradley, C. Owens, R Liu, Kurt T. Barnhart, Veronica Gillispie
In: Journal of Minimally Invasive Gynecology · 2019 · vol. 26(7) , pp. S67 · doi:10.1016/j.jmig.2019.09.666 · W2980910369
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study examined how fibroid location and size impacted elagolix's effectiveness in treating heavy menstrual bleeding in women with uterine fibroids.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK